Renaissance Dupont Circle Hotel
New Hampshire Ballroom
1143 New Hampshire Avenue NW
Washington, DC 20037

Overview
The Observational Medical Outcomes Partnership (OMOP) initial two-year program of work was designed to develop, implement, and empirically test the performance of a number of methods in identifying drug outcomes across multiple observational data sources. The research results will provide empiric evidence to inform the implementation of any systematic surveillance system regarding the methods, data, and infrastructure necessary to identify and track emerging safety issues. Study results and lessons learned will be shared in accordance with the public health mission of the Partnership.

Goals
Stakeholders met at the OMOP 2011 Symposium to discuss key OMOP results, tools, and lessons learned. During the OMOP Symposium, the following issues were discussed:

• Study results were discussed regarding the performance of the methods implemented across the databases in the research lab and the distributed network.
• The utility of OMOP-created tools were explored for data characterization, quality assurance, and outcome definitions to support standardized processes within an active surveillance system.
• Lessons learned were reviewed along the initial OMOP 2-year journey.
• Applications of the OMOP research beyond active surveillance.
• Stakeholders and leaders in pharmacovigilance discussed their perspectives on drug safety systems and the impact of the OMOP Research.